| REVIEW ARTICLE |
|
| Year : 2022 | Volume
: 1
| Issue : 2 | Page : 114-120 |
|
|
Epidemiology of infections in diabetes, pre and post-COVID era in India
Jayshree Swain, Jaspreet Singh, Ankit Manglunia, Sushree Jena, SL Sravya
Department of Endocrinology, IMS and SUM Medical College and Hospital, Bhubaneswar, Odisha, India
Correspondence Address:
Jayshree Swain
Department of Endocrinology, IMS and SUM Medical College and Hospital, Bhubaneswar - 751 003, Odisha
India
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/cdrp.cdrp_7_22
|
|
|
Infectious diseases are more common and severe in diabetes. Diabetes predisposes to various infections through alterations in innate and acquired immune defences. Outcomes of infection are worse in people with uncontrolled glycemia, including an increased mortality. The infections can affect all organs and all systems. In patients with diabetes, the infections can be broadly classified into two categories. Infections that are common in the general population have more severe clinical presentation and worse outcomes among patients with diabetes. The second group is of infections that are peculiar to patients with diabetes, being virtually rare in the normal population, such as foot infections, malignant external otitis, rhinocerebral mucormycosis, emphysematous pyelonephritis and gangrenous cholecystitis, etc. Epidemiological data on the true incidence of atypical and rare infections are scarce. This review will highlight the prevalence, consequences, severity, and pattern of infections in the population with diabetes in India. This review of epidemiological prevalence may guide the clinicians for early suspicion, identification of infectious disease, and right selection of the antimicrobial agents which may lead to a better outcome.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
